Oncology & Cancer

Cancer patients overlooked in COVID-19 vaccine rollout

Almost two-thirds of U.S. states failed to prioritize cancer patients for COVID-19 vaccinations, despite recommendations from the Centers for Disease Control and Prevention (CDC), according to a study being presented today ...

Oncology & Cancer

Patient economic burden for cancer care $21.1 billon in 2019

(HealthDay)—Patient economic burden associated with cancer care was projected to be $21.1 billion in 2019, according to a report published online Oct. 26 in the Journal of the National Cancer Institute.


Dexamethasone underused for adults hospitalized with COVID-19

(HealthDay)—For adults hospitalized with COVID-19, dexamethasone and remdesivir use increased over time, although dexamethasone is still somewhat underused, according to a study published online Aug. 17 in the Annals of ...

Oncology & Cancer

Considerable national costs attributed to cancer medical care

(HealthDay)—The national costs attributed to medical care for cancer are considerable and are projected to increase 34 percent by 2030 based on population growth, according to a study published online June 10 in Cancer ...

page 1 from 4